Arizona State Retirement System increased its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn an additional $0.7 with the CVR.

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Activist Ryan Hampton sees a major flaw in the proposed $7.4 billion bankruptcy settlement reached by the OxyContin maker. While it's potentially one of the largest opioid settlements ever, he ...

The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, P.R. China Bioinspired Engineering ...

US president Donald Trump has recently threatened to impose a 25% tariff on the EU, significantly escalating global trade tensions. Although these potential tariffs would impact the whole of the ...

RBC Capital analyst Douglas Miehm reiterated a Buy rating on Ligand Pharma (LGND – Research Report) yesterday and set a price target of $155.00. The company’s shares closed last Friday at $122.23.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) has been given a consensus recommendation of “Buy” by the six research firms that are currently covering the firm ...

With a thrust on strong operations over the past decade, Indian pharma production has outpaced global growth by over two times. Image: Sanjay Rawat India’s pharmaceutical sector is at a tipping point ...